A PHASE I AND DOSE-FINDING STUDY OF LENVATINIB (E7080) IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS

被引：0
|
作者：
Yamamoto, N. [1 ]
Nokihara, H. [1 ]
Yamada, Y. [2 ]
Honda, K. [1 ]
Wakui, H. [1 ]
Sasaki, T. [3 ]
Yusa, W. [3 ]
Tamura, T. [1 ]
机构：
[1] Natl Canc Ctr, Div Thorac Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Div Gastrointestinal Oncol, Tokyo, Japan
[3] Eisai & Co Ltd, Japan Asia Clin Res Sect, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt459.77
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I dose finding study of E7080 in patients (pts) with advanced malignancies
    Glen, H.
    Boss, D.
    Evans, T. R.
    Roelvink, M.
    Saro, J. M.
    Bezodis, P.
    Copalu, W.
    Das, A.
    Crosswell, G.
    Schellens, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Phase I dose escalation study and biomarker analysis of E7080 in patients with advanced solid tumors
    Yamada, K.
    Hirata, T.
    Fujiwara, Y.
    Nokihara, H.
    Yamamoto, N.
    Yamada, Y.
    Koizumi, F.
    Nishio, K.
    Koyama, N.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
    Yamada, Kazuhiko
    Yamamoto, Noboru
    Yamada, Yasuhide
    Nokihara, Hiroshi
    Fujiwara, Yutaka
    Hirata, Taizo
    Koizumi, Fumiaki
    Nishio, Kazuto
    Koyama, Noriyuki
    Tamura, Tomohide
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2528 - 2537
  • [4] Phase I dose-escalation study of E7080, a multikinase inhibitor, in patients with advanced solid tumors
    Nemunaitis, J. J.
    Senzer, N. N.
    Kurzrock, R.
    Ng, C. S.
    Das, A.
    Atienza, R. S.
    Zang, E. A.
    Jansen, M.
    Ashworth, S.
    Hong, D. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Phase I dose escalation study of E7080, a novel anti-angiogenic multikinase inhibitor, in Japanese patients with advanced solid tumors
    Yamada, K.
    Fujiwara, Y.
    Yamamoto, N.
    Yamada, Y.
    Suzuki, S.
    Kobayashi, N.
    Koizumi, F.
    Nishio, K.
    Tamura, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Treatment of advanced solid tumors with golvatinib (E7050) in combination with lenvatinib (E7080)
    Kwak, E. L.
    Juric, D.
    Cleary, J. M.
    Cote, G.
    Hilton, J. F.
    Flaherty, K. T.
    Wood, K.
    Rance, C.
    Barrett, S.
    Shapiro, G. I.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 158 - 158
  • [7] A phase I study of E7080 in patients (pts) with advanced malignancies
    Glen, H.
    Boss, D. R.
    Morrison, R.
    Roelvink, M.
    Wanders, J.
    Mazur, A.
    Gupta, A.
    Das, A.
    Evans, T. R.
    Schellens, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] A Phase I, dose-finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors*,†
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Yamada, Yasuhide
    Goto, Yasushi
    Tanioka, Maki
    Shibata, Takashi
    Yamada, Kazuhiko
    Asahina, Hajime
    Kawata, Toshio
    Shi, Xiaojin
    Tamura, Tomohide
    CANCER SCIENCE, 2012, 103 (03) : 504 - 509
  • [9] Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study
    Hajime Asahina
    Hiroshi Nokihara
    Noboru Yamamoto
    Yasuhide Yamada
    Yosuke Tamura
    Kazunori Honda
    Yoshitaka Seki
    Yuko Tanabe
    Hitoshi Shimada
    Xiaojin Shi
    Tomohide Tamura
    Investigational New Drugs, 2013, 31 : 677 - 684
  • [10] A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
    Boss, D. S.
    Glen, H.
    Beijnen, J. H.
    Keesen, M.
    Morrison, R.
    Tait, B.
    Copalu, W.
    Mazur, A.
    Wanders, J.
    O'Brien, J. P.
    Schellens, J. H. M.
    Evans, T. R. J.
    BRITISH JOURNAL OF CANCER, 2012, 106 (10) : 1598 - 1604
12345